Journal article
Precision medicine in the management of type 2 diabetes
- Abstract:
-
The study of type 2 diabetes has been driven by advances in human genetics, epigenetics, biomarkers, mechanistic studies, and large clinical trials, enabling new insights into disease susceptibility, pathophysiology, progression, and development of complications. Simultaneously, several new drug classes with different mechanisms of action have been introduced over the past two decades, accompanied by data about cardiovascular safety and non-glycaemic outcomes. In this Review, we critically ex...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 271.7KB)
-
- Publisher copy:
- 10.1016/S2213-8587(18)30052-4
Authors
Funding
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Diabetes and Endocrinology Journal website
- Volume:
- 6
- Issue:
- 11
- Pages:
- 891-900
- Publication date:
- 2018-04-23
- Acceptance date:
- 2018-04-23
- DOI:
- ISSN:
-
2213-8595
- Source identifiers:
-
845670
Item Description
- Pubs id:
-
pubs:845670
- UUID:
-
uuid:8719ebd4-74ee-48bd-96c0-38de62e42f0a
- Local pid:
- pubs:845670
- Deposit date:
- 2018-05-02
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Elsevier Ltd. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S2213-8587(18)30052-4
If you are the owner of this record, you can report an update to it here: Report update to this record